<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Medipharm Labs Corp — News on 6ix</title>
<link>https://6ix.com/company/medipharm-labs-corp</link>
<description>Latest news and press releases for Medipharm Labs Corp on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 27 Apr 2026 12:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/medipharm-labs-corp" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835f99878dffbe2df130f56.webp</url>
<title>Medipharm Labs Corp</title>
<link>https://6ix.com/company/medipharm-labs-corp</link>
</image>
<item>
<title>MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-positioned-to-serve-growing-us-pharmaceutical-and-clinical-research-demand-following-cannabis-rescheduling</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-positioned-to-serve-growing-us-pharmaceutical-and-clinical-research-demand-following-cannabis-rescheduling</guid>
<pubDate>Mon, 27 Apr 2026 12:30:00 GMT</pubDate>
<description>On April 22, 2026, the U.S. Department of Justice and Drug Enforcement Administration&#x2019;s fi...</description>
</item>
<item>
<title>MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-reports-full-year-and-fourth-quarter-2025-results-with-over-40percent-annual-growth-in-international-medical-revenue</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-reports-full-year-and-fourth-quarter-2025-results-with-over-40percent-annual-growth-in-international-medical-revenue</guid>
<pubDate>Mon, 30 Mar 2026 11:45:00 GMT</pubDate>
<description>FY 2025 revenue of&#xA0;$45.1 million, an increase of 8% over 2024 International Medical Cannabi...</description>
</item>
<item>
<title>MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-sets-date-to-report-full-year-and-fourth-quarter-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-sets-date-to-report-full-year-and-fourth-quarter-2025-financial-results</guid>
<pubDate>Wed, 25 Mar 2026 23:05:48 GMT</pubDate>
<description>TORONTO, March 25, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. &#xA0;(TSX:&#xA0; LABS ) (OTC...</description>
</item>
<item>
<title>MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-announces-ceo-transition-david-pidduck-to-step-down-cfo-greg-hunter-appointed-interim-ceo</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-announces-ceo-transition-david-pidduck-to-step-down-cfo-greg-hunter-appointed-interim-ceo</guid>
<pubDate>Mon, 19 Jan 2026 13:00:00 GMT</pubDate>
<description>TORONTO, Jan. 19, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: ...</description>
</item>
<item>
<title>MediPharm Labs to Enter New Market with Costa Rica Supply Agreement</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-to-enter-new-market-with-costa-rica-supply-agreement</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-to-enter-new-market-with-costa-rica-supply-agreement</guid>
<pubDate>Tue, 13 Jan 2026 13:00:00 GMT</pubDate>
<description>TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: ...</description>
</item>
<item>
<title>Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/historic-us-cannabis-rescheduling-unlocks-potential-growth-opportunities-for-medipharm-labs-backed-by-the-companys-suite-of-licenses-and-proven-us-clinical-trial-supply-experience</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/historic-us-cannabis-rescheduling-unlocks-potential-growth-opportunities-for-medipharm-labs-backed-by-the-companys-suite-of-licenses-and-proven-us-clinical-trial-supply-experience</guid>
<pubDate>Fri, 19 Dec 2025 13:45:00 GMT</pubDate>
<description>TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: ...</description>
</item>
<item>
<title>MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-announces-board-of-directors-changes-shelley-potts-steps-down-michael-bumby-returns</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-announces-board-of-directors-changes-shelley-potts-steps-down-michael-bumby-returns</guid>
<pubDate>Thu, 11 Dec 2025 01:30:00 GMT</pubDate>
<description>TORONTO, Dec. 10, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: ...</description>
</item>
<item>
<title>MediPharm Labs Completes First Shipment to France</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-completes-first-shipment-to-france</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-completes-first-shipment-to-france</guid>
<pubDate>Thu, 04 Dec 2025 13:40:00 GMT</pubDate>
<description>TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: ...</description>
</item>
<item>
<title>MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/medipharm-announces-complete-dismissal-of-defamation-action-initiated-by-apollo-nobul-and-regan-mcgee-under-ontario-anti-slapp-law</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/medipharm-announces-complete-dismissal-of-defamation-action-initiated-by-apollo-nobul-and-regan-mcgee-under-ontario-anti-slapp-law</guid>
<pubDate>Fri, 14 Nov 2025 15:00:00 GMT</pubDate>
<description>TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: ...</description>
</item>
<item>
<title>MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/medipharm-advances-global-reach-in-q3-2025-with-double-digit-revenue-growth-and-strong-international-medical-cannabis-gains</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/medipharm-advances-global-reach-in-q3-2025-with-double-digit-revenue-growth-and-strong-international-medical-cannabis-gains</guid>
<pubDate>Thu, 13 Nov 2025 13:00:00 GMT</pubDate>
<description>Q3 2025 Revenue of&#xA0;$11.4 Million, an Increase of 17% over Q3 2024 83% Growth in Year-Ove...</description>
</item>
<item>
<title>MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-sets-date-to-report-third-quarter-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-sets-date-to-report-third-quarter-2025-financial-results</guid>
<pubDate>Mon, 10 Nov 2025 23:00:00 GMT</pubDate>
<description>TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS ) (OTCQB: ...</description>
</item>
<item>
<title>/U P D A T E -- MediPharm Labs Corp./</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/u-p-d-a-t-e-medipharm-labs-corp</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/u-p-d-a-t-e-medipharm-labs-corp</guid>
<pubDate>Fri, 07 Nov 2025 21:30:00 GMT</pubDate>
<description>/U P D A T E -- MediPharm Labs Corp./ Canada NewsWire In the news release, MediPhar...</description>
</item>
<item>
<title>MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-files-proxy-materials-issues-chairs-letter-to-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-files-proxy-materials-issues-chairs-letter-to-shareholders</guid>
<pubDate>Fri, 07 Nov 2025 21:19:00 GMT</pubDate>
<description>MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders Canada NewsWi...</description>
</item>
<item>
<title>MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/medipharm-strengthens-global-position-in-q2-2025-with-14percent-revenue-growth-and-50percent-increase-in-international-medical-cannabis</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/medipharm-strengthens-global-position-in-q2-2025-with-14percent-revenue-growth-and-50percent-increase-in-international-medical-cannabis</guid>
<pubDate>Thu, 14 Aug 2025 11:30:00 GMT</pubDate>
<description>Q2 Revenue of&#xA0;$11.8 Million, an Increase of 14% over Q2 2024 50% Growth in Revenue for I...</description>
</item>
<item>
<title>MediPharm Labs Positioned for Unique Opportunities on Possible Rescheduling of Cannabis in the United States</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-positioned-for-unique-opportunities-on-possible-rescheduling-of-cannabis-in-the-united-states</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-positioned-for-unique-opportunities-on-possible-rescheduling-of-cannabis-in-the-united-states</guid>
<pubDate>Wed, 13 Aug 2025 11:30:00 GMT</pubDate>
<description>MediPharm Labs Positioned for Unique Opportunities on Possible Rescheduling of Cannabis in the Un...</description>
</item>
<item>
<title>MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-sets-date-to-report-second-quarter-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-sets-date-to-report-second-quarter-2025-financial-results</guid>
<pubDate>Mon, 11 Aug 2025 11:38:00 GMT</pubDate>
<description>TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS ) (OTC...</description>
</item>
<item>
<title>MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-expands-leading-cbn-oil-portfolio-with-the-launch-of-new-nighttime-inhaler</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/medipharm-labs-expands-leading-cbn-oil-portfolio-with-the-launch-of-new-nighttime-inhaler</guid>
<pubDate>Thu, 24 Jul 2025 11:00:00 GMT</pubDate>
<description>TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: ...</description>
</item>
<item>
<title>MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/medipharm-announces-voting-results-from-the-2025-annual-and-special-meeting-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/medipharm-announces-voting-results-from-the-2025-annual-and-special-meeting-of-shareholders</guid>
<pubDate>Tue, 17 Jun 2025 14:27:54 GMT</pubDate>
<description>TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: ...</description>
</item>
<item>
<title>MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/medipharm-cautions-shareholders-to-await-final-results-of-annual-and-special-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/medipharm-cautions-shareholders-to-await-final-results-of-annual-and-special-meeting</guid>
<pubDate>Mon, 16 Jun 2025 17:22:45 GMT</pubDate>
<description>TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: ...</description>
</item>
<item>
<title>Apollo Capital Wins Proxy Contest at MediPharm Labs</title>
<link>https://6ix.com/company/medipharm-labs-corp/news/apollo-capital-wins-proxy-contest-at-medipharm-labs</link>
<guid isPermaLink="true">https://6ix.com/company/medipharm-labs-corp/news/apollo-capital-wins-proxy-contest-at-medipharm-labs</guid>
<pubDate>Mon, 16 Jun 2025 15:15:00 GMT</pubDate>
<description>MediPharm Labs&#x2019; Board&#x2019;s Material and Unprecedented Breaches of Securities Laws ...</description>
</item>
</channel>
</rss>